Cargando…
Use of bone marrow cells (BMCS) added to Platelet-Rich Plasma (PRP) for treatment of bone degenerative processes in JIA patients: a case report
Autores principales: | Alpigiani, MG, Salvati, P, Muraca, M, Callegari, S, Tripodi, G, Lorini, R, Michelis, MB, Boero, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194544/ http://dx.doi.org/10.1186/1546-0096-9-S1-P188 |
Ejemplares similares
-
PReS-FINAL-2092: Bone marrow cells (BMC) added to platelet-rich plasma (PRP) for treatment of bone degenerative processes in JIA patients: follow-up of 2 cases
por: Salvati, P, et al.
Publicado: (2013) -
Pregnancy outcomes in women affected by juvenile idiopathic arthritis (JIA)
por: Alpigiani, Maria Giannina, et al.
Publicado: (2014) -
Abatacept for severe anti-TNF-alfa refractory JIA-associated uveitis: one year follow-up
por: Alpigiani, MG, et al.
Publicado: (2011) -
Juvenile idiopathic arthritis (JIA) and early diagnosis of temporo-mandibular joint (TMJ) disorders
por: Alpigiani, MG, et al.
Publicado: (2008) -
Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)